Drilldown: Medicines
Appearance
Medicines > classes
:
Sedative-hypnotic
or
[[:Category:Antithyroid_agents|Antithyroid agent]]
& routes:
Oral 
:
Sedative-hypnotic
or
[[:Category:Antithyroid_agents|Antithyroid agent]]
& routes:
Oral 
Use the filters below to narrow your results.
Positive allosteric modulator of the GABA<sub>A</sub> receptor at the benzodiazepine binding site; increases frequency of Cl<sup>−</sup> channel opening, producing anxiolytic, sedative, hypnotic, anticonvulsant, and skeletal-muscle relaxant effects. (1) ·
'"`UNIQ--vote-00000ECD-QINU`"' Agranulocytosis is the most-feared adverse effect (~0.3%, usually first 90 days of treatment; warn patients to seek urgent CBC for fever or severe sore throat). Hepatotoxicity is class-recognized but more often associated with PTU'"`UNIQ--ref-00000ECE-QINU`"'. (1)
Showing below up to 2 results in range #1 to #2.

